ERBB2 and esophageal adenocarcinoma: Since ER signalling pathways are known to interact with several pathways that are highly relevant to oncogenesis, the expression of three key molecules (p53, EGFR, and HER2) was assessed in oesophageal adenocarcinoma cells.